Cognetivity Neurosciences (CGNSF) Stock Price, Quote, News & History

Cognetivity Neurosciences Ltd (CGNSF) Stock Price, Quote, News & History

CGNSFOTCEM

Trade with Public

At close: Apr 14, 5:00 PM EST

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$89.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Cognetivity Neurosciences Ltd News

UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round

A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd.

Lara Goldstein

Partner Content

Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market

Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression

Ketamine One, a Canada-based health and wellness company focused on treatments for mental health, is teaming up with Cognetivity Neurosciences (OTCMKTS: CGNSF) for a collaborative study on treatments for PTSD and depression, the companies announced in a

Aaron Bry

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-3.85M

Investing Cash Flow (TTM)

-24.24K

Financing Cash Flow (TTM)

-228.81K

Free Cash Flow (TTM)

-3.88M

Capital Expenditure (TTM)

-24.24K

Net Change in Cash (TTM)

-4.11M

Valuation Metrics

Enterprise Value

$977.49K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$2.74M

LT Debt

$1.37M

LT Debt Issuance (TTM)

-$152.89K

LT Debt Repayment (TTM)

Total Cash

$16.57K

Debt to Equity

Issuance of Debt (TTM)

-$165.02K

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$89.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cognetivity Neurosciences (CGNSF) stock?

You can purchase shares of Cognetivity Neurosciences (OTCEM:CGNSF) through any online brokerage.

View our list of the best stock brokerages

Who are Cognetivity Neurosciences (CGNSF) competitors?

There are no as such competitors for Cognetivity Neurosciences.

What is the forecast, or price target, for Cognetivity Neurosciences (CGNSF) stock?

There is no analysis for Cognetivity Neurosciences to provide a consensus price target.

What is the current price for Cognetivity Neurosciences (CGNSF)?

The stock price for Cognetivity Neurosciences (OTCEM: CGNSF) is $0.000001 last updated December 30, 2025 at 1:12 PM EST.

Does Cognetivity Neurosciences (CGNSF) pay a dividend?

There are no upcoming dividends for Cognetivity Neurosciences.

When is Cognetivity Neurosciences (OTCEM:CGNSF) reporting earnings?

Cognetivity Neurosciences does not have any upcoming earnings scheduled.

Is Cognetivity Neurosciences (CGNSF) going to split?

There is no upcoming split for Cognetivity Neurosciences.

What sector and industry does Cognetivity Neurosciences (CGNSF) operate in?

Cognetivity Neurosciences is in the Healthcare sector and Health Information Services industry. They are listed on the OTCEM.

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$89.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Cognetivity Neurosciences Ltd News

UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round

A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd.

Lara Goldstein

Partner Content

Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market

Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression

Aaron Bry